---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-006749"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2024-01-25T23:59:59+00:00"
generated_at: "2026-06-06T18:28:22.026947+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# TriSalus Life Sciences grants CFO Sean Murphy option for 125,000 shares at $9.28

## Summary
- Granted on Jan 24, 2024, under the 2023 Equity Incentive Plan.
- Exercise price of $9.28 per share, equal to grant-date market price.
- Vests 25% on first anniversary, remaining 75% in 36 equal monthly installments.
- Contingent on Mr. Murphy's continuous service through each vesting date.
- Award recognizes CFO's 2023 performance and aligns long-term incentives.

## SEC filing metadata
- accession: 0001104659-24-006749
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2024-01-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465924006749/0001104659-24-006749-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465924006749/tm244105d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-006749
- JSON: https://secwatch.observer/filing/0001104659-24-006749.json
- Plain text: https://secwatch.observer/filing/0001104659-24-006749.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.